National Heart, Lung, and Blood Institute; Notice of Closed Meetings, 46171-46172 [2023-15228]
Download as PDF
<![CDATA[
ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 137 / Wednesday, July 19, 2023 / Notices
regarding progress made since the
second public meeting, including
protocol development, evidence review
and synthesis, systematic review
findings, and plans for future
Committee work. The Committee will
also hear oral comments from the public
at this meeting. In accordance with
FACA, deliberations of the Committee
will occur in a public forum.
Meeting Agendas: The specific agenda
will be announced in advance of the
meeting on DietaryGuidelines.gov.
Meeting Registration: This Committee
meeting is open to the public. The
meeting will be accessible online via
livestream and recorded for later
viewing. Registration is required for the
livestream and will open on Thursday,
August 10, 2023. To register, go to
DietaryGuidelines.gov and click on the
link for ‘‘Meeting Registration.’’
Meeting materials for each meeting
will be accessible at
DietaryGuidelines.gov. Materials may be
requested by email at
DietaryGuidelines@hhs.gov.
Oral Comments: The Committee
invites the public to present oral
comments for up to two minutes on
Tuesday, September 12, 2023. Preregistration is required, and the number
of commenters is limited based on the
time available. Registration for oral
comments will open on Thursday,
August 10, 2023, at 10:00 a.m. Eastern
Time. Oral comments will be confirmed
on a first-come, first-served basis. Oral
comments are limited to one
representative per organization. All
commenters’ remarks should be
respectful and given in a manner that
recognizes and protects the dignity of
the proceedings. Oral comments should
focus on the Committee’s work and be
directed to the entire Committee, not
individual members.
Registration for Oral Comments:
Requests to present oral comments can
be made by going to
DietaryGuidelines.gov and clicking on
the link for ‘‘Meeting Registration.’’ For
registration to be accepted, a written
outline or a summary of the intended
oral comment will be required as part of
the registration process. Please limit
your written outline or summary to no
more than 400 words. A confirmation
email with instructions will be sent to
confirmed speakers from
DietaryGuidelines@hhs.gov.
Public Comments: A call for written
public comment to the Committee
opened on January 19, 2023, and will
remain open throughout the
Committee’s deliberations. Written
comments may be submitted at
VerDate Sep<11>2014
00:36 Jul 19, 2023
Jkt 259001
46171
Regulations.gov (Document ID: HHS–
OASH–2022–0021–0001).
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Paul Reed,
Deputy Assistant Secretary for Health, Office
of Disease Prevention and Health Promotion.
National Institutes of Health
[FR Doc. 2023–15342 Filed 7–18–23; 8:45 am]
BILLING CODE 4150–32–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Clinical Trial
Implementation Cooperative Agreement (U01
Clinical Trial Required).
Date: August 10, 2023.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G41,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Kelly L. Hudspeth, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Allergy and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane, Room
3G41, Rockville, MD 20852, 240–669–5067
kelly.hudspeth@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: July 13, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–15283 Filed 7–18–23; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
NHLBI Biorepository Contract Review.
Date: August 16, 2023.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Kristen Page, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 209–B,
Bethesda, MD 20892, (301) 827–7953,
kristen.page@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Pediatric Heart Network Data Coordinating
Center (U24).
Date: August 16, 2023.
Time: 1:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Susan Wohler Sunnarborg,
Ph.D., Scientific Review Officer, Office of
Scientific Review/DERA, National, Heart,
Lung, and Blood Institute, National Institutes
of Health, 6705 Rockledge Drive, Room 208–
Z, Bethesda, MD 20892, (301) 827–7987,
susan.sunnarborg@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Pediatric Heart Network Clinical Research
Centers (UM1).
Date: August 17–18, 2023.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Susan Wohler Sunnarborg,
Ph.D., Scientific Review Officer, Office of
E:\FR\FM\19JYN1.SGM
19JYN1
46172
Federal Register / Vol. 88, No. 137 / Wednesday, July 19, 2023 / Notices
Scientific Review/DERA, National, Heart,
Lung, and Blood Institute, National Institutes
of Health, 6705 Rockledge Drive, Room 208–
Z, Bethesda, MD 20892, (301) 827–7987,
susan.sunnarborg@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Opportunities for Collaborative Research at
the NIH Clinical Center (U01).
Date: August 24, 2023.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Zhihong Shan, Ph.D., MD,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 205–J,
Bethesda, MD 20892, (301) 827–7085,
zhihong.shan@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: July 13, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–15228 Filed 7–18–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
ddrumheller on DSK120RN23PROD with NOTICES1
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Vaccine Adjuvant Discovery
Program (N01).
Date: August 21–22, 2023.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
00:36 Jul 19, 2023
Jkt 259001
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G41,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Tara Capece, Ph.D., MPH,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G41, Rockville, MD
20852, 240–191–4281, capecet2@
niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS).
Dated: July 13, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–15282 Filed 7–18–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director; Notice of Charter
Renewal
In accordance with Title 41 of the
U.S. Code of Federal Regulations,
section 102–3.65(a), notice is hereby
given that the Charter for the Novel and
Exceptional Technology and Research
Advisory Committee, was renewed for
an additional two-year period on June
30, 2023. It is determined that the Novel
and Exceptional Technology Research
Advisory Committee is in the public
interest in connection with the
performance of duties imposed on the
National Institutes of Health by law, and
that these duties can best be performed
through the advice and counsel of this
group.
Inquires may be directed to Claire
Harris, Director, Office of Federal
Advisory Committee Policy, Office of
the Director, National Institutes of
Health, 6701 Democracy Boulevard,
Suite 100, Bethesda, Maryland 20892
(Mail code 4875), Telephone (301) 496–
2123, or harriscl@mail.nih.gov.
Dated: July 13, 2023.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–15246 Filed 7–18–23; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Environmental
Health Sciences; Notice of Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Board of Scientific
Counselors, National Institute
Environmental Health Sciences.
This will be a hybrid meeting held inperson and virtually and will be open to
the public as indicated below.
Individuals who plan to attend inperson or view the virtual meeting and
need special assistance or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The meeting
can be accessed from the NIH Videocast
at the following link: https://
videocast.nih.gov/.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended for the review, discussion,
and evaluation of individual intramural
programs and projects conducted by the
National Institute Of Environmental
Health Sciences, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, National Institute Environmental
Health Sciences August ESBSC Meeting.
Date: August 27–29, 2023.
Closed: August 27, 2023, 7:00 p.m. to 8:00
p.m.
Agenda: Discussion of BSC Reviews.
Place: National Institute Environmental
Health Sciences, Building 101, Rodbell
Auditorium, 111 T.W. Alexander Drive,
Research Triangle Park, NC 27709 (Hybrid
Meeting).
Open: August 28, 2023, 8:30 a.m. to 10:00
a.m.
Agenda: Meeting Overview and Q & A
Session.
Place: National Institute Environmental
Health Sciences, Building 101, Rodbell
Auditorium, 111 T.W. Alexander Drive,
Research Triangle Park, NC 27709 (Hybrid
Meeting).
Open: August 28, 2023, 10:15 a.m. to 11:55
a.m.
Agenda: Q & A Session.
Place: National Institute Environmental
Health Sciences, Building 101, Rodbell
Auditorium, 111 T.W. Alexander Drive,
Research Triangle Park, NC 27709 (Hybrid
Meeting).
Closed: August 28, 2023, 11:55 a.m. to
12:40 p.m.
E:\FR\FM\19JYN1.SGM
19JYN1
]]>Agencies
[Federal Register Volume 88, Number 137 (Wednesday, July 19, 2023)]
[Notices]
[Pages 46171-46172]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-15228]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; NHLBI Biorepository Contract Review.
Date: August 16, 2023.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kristen Page, Ph.D., Scientific Review Officer,
Office of Scientific Review/DERA, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6705 Rockledge Drive, Room
209-B, Bethesda, MD 20892, (301) 827-7953, [email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Pediatric Heart Network Data Coordinating
Center (U24).
Date: August 16, 2023.
Time: 1:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Susan Wohler Sunnarborg, Ph.D., Scientific
Review Officer, Office of Scientific Review/DERA, National, Heart,
Lung, and Blood Institute, National Institutes of Health, 6705
Rockledge Drive, Room 208-Z, Bethesda, MD 20892, (301) 827-7987,
[email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Pediatric Heart Network Clinical Research
Centers (UM1).
Date: August 17-18, 2023.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Susan Wohler Sunnarborg, Ph.D., Scientific
Review Officer, Office of
[[Page 46172]]
Scientific Review/DERA, National, Heart, Lung, and Blood Institute,
National Institutes of Health, 6705 Rockledge Drive, Room 208-Z,
Bethesda, MD 20892, (301) 827-7987, [email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Opportunities for Collaborative Research at
the NIH Clinical Center (U01).
Date: August 24, 2023.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Zhihong Shan, Ph.D., MD, Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Room 205-J, Bethesda, MD 20892, (301) 827-7085,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: July 13, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-15228 Filed 7-18-23; 8:45 am]
BILLING CODE 4140-01-P
